Closed · RFA-AR-10-004 · CFDA 93.846 · Discretionary

Translation and/or Commercialization of Musculoskeletal and Skin Tissue Engineering and Regenerative Medicine Research SBIR [R43/R44]

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

Varies
Award range
Closed
Status
November 19, 2009
Close date
-
Expected awards

The verdict

Translation and/or Commercialization of Musculoskeletal and Skin Tissue Engineering and Regenerative Medicine Research SBIR [R43/R44] is a closed discretionary listing from National Institutes of Health that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

Varies
award range
Closed
application status
93.846
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Translation and/or Commercialization of Muscu… is closed (last close November 19, 2009). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed November 19, 2009

Posted Apr 24 Closes Nov 19

Est. Total Funding

$1,500,000

Instrument

Grant

Description

Purpose. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) issues this Funding Opportunity Announcement (FOA) to solicit Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to accelerate translation and/or commercialization of musculoskeletal and skin tissue engineering and regenerative medicine research. The focus of this FOA is on pre-clinical studies with potential to immediately lead to phase I human clinical trials, or on development of pre-clinical animal models to assess safety and efficacy of potential commercial products in musculoskeletal and skin tissue engineering and regenerative medicine. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I and Phase II. This FOA does not support Fast Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 3-5 projects awarded as a result of this announcement is $1.5 million total costs for fiscal year 2010. Future year amounts will depend on annual appropriations.

Small-business / for-profit corridor · RFA-AR-10-004

Translation and/or Commercialization of Muscu… prints a for-profit / small-business applicant door (Small businesses). Treat the listing as business-facing unless the full Grants.gov announcement narrows it further. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). 789 other National Institutes of Health listings share this eligibility-code string (6% of 12,420).

Code 23
Small businesses

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Translation and/or Commercialization of Muscu… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.846 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants